Nxera Pharma Co., Ltd. 4565.T Stock
Nxera Pharma Co., Ltd. Price Chart
Nxera Pharma Co., Ltd. 4565.T Financial and Trading Overview
| Nxera Pharma Co., Ltd. stock price | 1522 JPY |
| Previous Close | 2840 JPY |
| Open | 2818 JPY |
| Bid | 2884 JPY x 0 |
| Ask | 2888 JPY x 0 |
| Day's Range | 2816 - 2899 JPY |
| 52 Week Range | 991 - 3185 JPY |
| Volume | 1.14M JPY |
| Avg. Volume | 1.23M JPY |
| Market Cap | 238.82B JPY |
| Beta (5Y Monthly) | 0.946743 |
| PE Ratio (TTM) | 648.53937 |
| EPS (TTM) | -87.15 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 27, 2015 |
| 1y Target Est | 3328.6 JPY |
4565.T Valuation Measures
| Enterprise Value | 209.13B JPY |
| Trailing P/E | 648.53937 |
| Forward P/E | 1238.6267 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 15.514805 |
| Price/Book (mrq) | 4.061391 |
| Enterprise Value/Revenue | 13.586 |
| Enterprise Value/EBITDA | 47.379 |
Trading Information
Nxera Pharma Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.946743 |
| 52-Week Change | 178.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3185 JPY |
| 52 Week Low | 991 JPY |
| 50-Day Moving Average | 2803.44 JPY |
| 200-Day Moving Average | 2268.33 JPY |
4565.T Share Statistics
| Avg. Volume (3 month) | 1.23M JPY |
| Avg. Daily Volume (10-Days) | 904.3K JPY |
| Shares Outstanding | 81.92M |
| Float | 62.44M |
| Short Ratio | N/A |
| % Held by Insiders | 10.32% |
| % Held by Institutions | 30.73% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 6.82% |
| Operating Margin (ttm) | 19.83% |
| Gross Margin | 95.25% |
| EBITDA Margin | 28.67% |
Management Effectiveness
| Return on Assets (ttm) | 1.96% |
| Return on Equity (ttm) | 1.83% |
Income Statement
| Revenue (ttm) | 15.39B JPY |
| Revenue Per Share (ttm) | 187.98 JPY |
| Quarterly Revenue Growth (yoy) | -15.69% |
| Gross Profit (ttm) | 14.64B JPY |
| EBITDA | 4.41B JPY |
| Net Income Avi to Common (ttm) | 1.05B JPY |
| Diluted EPS (ttm) | 4.45 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 66.35B JPY |
| Total Cash Per Share (mrq) | 809.93 JPY |
| Total Debt (mrq) | 29.88B JPY |
| Total Debt/Equity (mrq) | 51.33 JPY |
| Current Ratio (mrq) | 20.416 |
| Book Value Per Share (mrq) | 710.594 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 10.39B JPY |
| Levered Free Cash Flow (ttm) | -1253250048 JPY |
Profile of Nxera Pharma Co., Ltd.
| Country | Japan |
| State | N/A |
| City | Tokyo |
| Address | PMO Hanzomon |
| ZIP | 102-0083 |
| Phone | 81 3 5210 3290 |
| Website | https://soseiheptares.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 207 |
Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; HTL0016878 for Schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; and PF-07258669 for anorexia. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, Neurocrine Biosciences, Novartis, Verily, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.
Q&A For Nxera Pharma Co., Ltd. Stock
What is a current 4565.T stock price?
Nxera Pharma Co., Ltd. 4565.T stock price today per share is 1522 JPY.
How to purchase Nxera Pharma Co., Ltd. stock?
You can buy 4565.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nxera Pharma Co., Ltd.?
The stock symbol or ticker of Nxera Pharma Co., Ltd. is 4565.T.
Which industry does the Nxera Pharma Co., Ltd. company belong to?
The Nxera Pharma Co., Ltd. industry is Biotechnology.
How many shares does Nxera Pharma Co., Ltd. have in circulation?
The max supply of Nxera Pharma Co., Ltd. shares is 89.45M.
What is Nxera Pharma Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Nxera Pharma Co., Ltd. PE Ratio is now.
What was Nxera Pharma Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Nxera Pharma Co., Ltd. EPS is -87.15 JPY over the trailing 12 months.
Which sector does the Nxera Pharma Co., Ltd. company belong to?
The Nxera Pharma Co., Ltd. sector is Healthcare.
Nxera Pharma Co., Ltd. 4565.T included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}